Imiquimod and Influenza Vaccine for Immunocompromised Patients

NCT02960815 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Influenza Vaccine

Interventions

BIOLOGICAL: Intanza
BIOLOGICAL: Mutagrip
DRUG: Aldara

Sponsor

University of Lausanne Hospitals